These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20185423)

  • 1. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.
    Burkhardt O; Ewig S; Haagen U; Giersdorf S; Hartmann O; Wegscheider K; Hummers-Pradier E; Welte T
    Eur Respir J; 2010 Sep; 36(3):601-7. PubMed ID: 20185423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
    Albrich WC; Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Bachli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Gaillat J; Schuetz P; Regez K; Bossart R; Schild U; Mueller B;
    Arch Intern Med; 2012 May; 172(9):715-22. PubMed ID: 22782201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
    Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
    Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.
    Branche AR; Walsh EE; Vargas R; Hulbert B; Formica MA; Baran A; Peterson DR; Falsey AR
    J Infect Dis; 2015 Dec; 212(11):1692-700. PubMed ID: 25910632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study.
    Schuetz P; Christ-Crain M; Albrich W; Zimmerli W; Mueller B;
    Virulence; 2010; 1(2):88-92. PubMed ID: 21178422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial.
    Baer G; Baumann P; Buettcher M; Heininger U; Berthet G; Schäfer J; Bucher HC; Trachsel D; Schneider J; Gambon M; Reppucci D; Bonhoeffer JM; Stähelin-Massik J; Schuetz P; Mueller B; Szinnai G; Schaad UB; Bonhoeffer J
    PLoS One; 2013; 8(8):e68419. PubMed ID: 23936304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of dynamic monitoring of procalcitonin in guiding the use of antibiotics in patients with sepsis in ICU].
    Liu BH; Li HF; Lei Y; Zhao SX; Sun ML
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):690-3. PubMed ID: 24225216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection biomarkers in primary care patients with acute respiratory tract infections-comparison of Procalcitonin and C-reactive protein.
    Meili M; Kutz A; Briel M; Christ-Crain M; Bucher HC; Mueller B; Schuetz P
    BMC Pulm Med; 2016 Mar; 16():43. PubMed ID: 27009083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.